Nationwide Fund Advisors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-452,879
Closed -$76.4M 2413
2017
Q3
$76.4M Buy
452,879
+33,621
+8% +$5.08M 0.3% 44
2017
Q2
$60.1M Buy
419,258
+25,908
+7% +$3.48M 0.24% 52
2017
Q1
$49.2M Buy
393,350
+5,190
+1% +$602K 0.2% 78
2016
Q4
$43.7M Buy
388,160
+69,548
+22% +$8.06M 0.18% 96
2016
Q3
$41M Buy
318,612
+48,493
+18% +$5.81M 0.17% 99
2016
Q2
$29.5M Buy
270,119
+97,002
+56% +$9.65M 0.13% 169
2016
Q1
$22.8M Buy
173,117
+28,018
+19% +$2.37M 0.1% 235
2015
Q4
$13.1M Buy
145,099
+26,197
+22% +$2.22M 0.06% 452
2015
Q3
$11M Buy
118,902
+28,116
+31% +$2.48M 0.05% 487
2015
Q2
$5.97M Sell
90,786
-31,242
-26% -$2.08M 0.02% 874
2015
Q1
$8.73M Sell
122,028
-20,872
-15% -$1.13M 0.04% 679
2014
Q4
$5.44M Sell
142,900
-5,445
-4% -$172K 0.02% 889
2014
Q3
$3.68M Sell
148,345
-6,039
-4% -$153K 0.02% 1119
2014
Q2
$3.88M Buy
+154,384
New +$3.59M 0.02% 1127
2014
Q1
Sell
-121,672
Closed -$3.25M 3223
2013
Q4
$3.25M Buy
121,672
+41,030
+51% +$1.01M 0.01% 1188
2013
Q3
$1.54M Buy
80,642
+53,675
+199% +$1.23M 0.01% 1592
2013
Q2
$581K Buy
+26,967
New +$542K ﹤0.01% 1961

Other funds holding ABMD

Nationwide Fund Advisors's ABMD Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Abiomed Inc (ABMD) in Q4 2017, closing a stake of 452,879 shares — an estimated $76.4M sold.

Nationwide Fund Advisors first reported a position in ABMD in Q2 2013 and held it in 17 quarters. The position peaked at $76.4M in Q3 2017. 361 funds tracked by Wall St. Rank hold ABMD as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Abiomed Inc position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 452,879 Abiomed Inc shares in Q4 2017, an estimated $76.4M.
  • Nationwide Fund Advisors first reported a position in Abiomed Inc in Q2 2013 and held it in 17 quarters.
  • Nationwide Fund Advisors's Abiomed Inc position peaked at $76.4M in Q3 2017.
  • 361 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.